A validated method for the detection of ?9-tetrahydrocannabinol and 11-nor-9-carboxy-?9-tetrahydrocannabinol in oral fluid samples by liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry

Journal of Analytical Toxicology

Volumn 31, Issue 3, 2007, Pages 157-164

  Quintela, Oscar ^a   Andrenyak, David M ^a   Hoggan, Archie M ^a   Crouch, Dennis J ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TETRAHYDROCANNABINOL; TETRAHYDROCANNABINOL DERIVATIVE;

ACCURACY; ARTICLE; CHEMICAL STRUCTURE; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; QUADRUPOLE MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY;

EID: 34247351214     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/31.3.157     Document Type: Article

References (48)

1. L.D. Johnston, P.M. O'Malley, J.G. Bachman, and J.E. Schulenberg. Monitoring the Future national results on adolescent drug use: overview of key findings, 2005. (NIH Publication No. 05-5726). National Institute on Drug Abuse, Bethesda, MD, 2006.
2. D.J. Crouch, J.M. Walsh, R. Flegel, L. Cangianelli, J. Baudys, and R. Atkins. An evaluation of selected oral fluid point-of-collection drug-testing devices. J. Anal. Toxicol. 29: 244-248 (2005).
3. J.M. Walsh, R. Flegel, D.J. Crouch, L. Cangianelli, and J. Baudys. An evaluation of rapid point-of-collection oral fluid drug-testing devices. J. Anal. Toxicol. 27: 429-439 (2003).
4. A.G. Verstraete. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges. Forensic Sci. Int. 150(2-3): 143-150 (2005).
5. 9- tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J. Anal. Toxicol. 28: 394-399 (2004).
6. T. Nadulski, F. Sporkert, M. Schnelle, A.M. Stadelmann, P. Roser, T. Schefter, and F. Pragst. Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract. J. Anal. Toxicol. 29: 782-789 (2005).
7. 9-tetrahydrocannabinol from rabbit plasma by gas chromatography-mass spectrometry using two ionization techniques. J. Chromatogr. B 810(2): 283-290 (2004).
8. 9-THC in whole blood using gas chromatography-mass spectrometry. J. Anal. Toxicol. 26: 575-581 (2002).
9. P.M. Kemp, I.K. Abukhalaf, J.E. Manno, B.R. Manno, D.D. Alford, and G.A. Abusada. Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS. J. Anal. Toxicol. 19: 285-291 (1995).
10. 9-tetrahydrocannabinol concentrations. Clin. Chem. 51(12): 2289-2295 (2005).
11. T. Saito. Validated gas chromatographic-negative ion chemical ionization mass spectrometric method for delta(9)-tetrahydrocannabinol in sweat patches. Clin. Chem. 50(11): 2083-2090 (2004).
12. 9-THC-COOH by gas chromatography/tandem mass spectrometry in negative chemical ionization mode. Rapid Commun. Mass Spectrom. 19(11): 1566-1568 (2005).
13. 9- tetrahydrocannabinol in human plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry. J. Anal. Toxicol. 25: 531-537 (2001).
14. D. Wilkins, H. Haughey, E. Cone, M. Huestis, R. Foltz, and D. Rollins. Quantitative analysis of THC, 11-OH-THC, and THC-COOH in human hair by negative ion chemical ionization mass spectrometry. J. Anal. Toxicol. 19: 483-491 (1995).
15. 9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in human plasma using solid phase extraction and gas chromatography-mass spectrometry with positive chemical ionization. J. Chromatogr. B 798(1): 145-154 (2003).
16. R.S. Niedbala, K.W Kardos, D.F. Fritch, S. Kardos, T. Fries, J. Waga, J. Robb, and E.J. Cone. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J. Anal. Toxicol. 25: 289-303 (2001).
17. 9-tetrahydrocannabinol levels in two postmortem blood samples. J. Anal. Toxicol. 21: 538-542 (1997).
18. 9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens. J. Anal. Toxicol. 30: 409-412 (2006).
19. 9-tetrahydrocannabinol (THCA) in whole blood using two-dimensional gas chromatography and EI-mass spectrometry. J. Anal. Toxicol. 30: 262-266 (2006).
20. 9-tetrahydrocannabinol-9-carboxylic acid in urine using high-performance liquid chromatography and electrospray ionization mass spectrometry. J. Chromatogr. B 732(1): 155-164 (1999).
21. W. Weinmann, S. Vogt, R. Goerke, C. Muller, and A. Bromberger. Simultaneous determination of THC-COOH and THC-COOH glucuronide in urine samples by LC/MS/MS. Forensic Sci. Int. 113(1-3): 381-387 (2000).
22. 9- tetrahydrocannabinol-9-carboxylic acid in a urine-based standard reference material by isotope-dilution liquid chromatography-mass spectrometry with electrospray ionization. J. Anal. Toxicol. 24: 385-389 (2000).
23. W. Weinmann, M. Goerner, S. Vogt, R. Goerke, and S. Pollak. Fast confirmation of 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol (THC-COOH) in urine by LC/MS/MS using negative atmospheric-pressure chemical ionisation (APCI). Forensic Sci. Int. 121(1-2): 103-107 (2001).
24. G. Skopp and L. Potsch. Stability of 11-nor-delta(9)- carboxytetrahydrocannabinol glucuronide in plasma and urine assessed by liquid chromatography-tandem mass spectrometry. Clin. Chem. 48(2): 301-306 (2002).
25. 9-tetrahydrocannabinol and two metabolites in pharmacokinetic study plasma samples. J. Chromatogr. B 803(2): 243-248 (2004).
26. 9- tetrahydrocannabinol and 11-nor-9-carboxy-?9-tetrahydrocannabinol in human plasma by high-performance liquid chromatography/tandem mass spectrometry. J. Mass Spectrom. 39(5): 526-531 (2004).
27. 9-tetrahydrocannabinol in oral fluid by liquid chromatography electrospray-mass-spectrometry. J. Chromatogr. B 810(2): 319-324 (2004).
28. A.A. Stolker, J. van Schoonhoven, A.J. de Vries, I. Bobeldijk-Pastorova, W.H. Vaes, and R. van den Berg. Determination of cannabinoids in cannabis products using liquid chromatographyion trap mass spectrometry. J. Chromatogr. A 1058(1-2): 143-151 (2004).
29. 9-tetrahydrocannabinol in oral fluid samples using solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry. Forensic Sci. Int. 150(2-3): 205-211 (2005).
30. 9- tetrahydrocannabinol in preserved oral fluid by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1082(1): 15-24 (2005).
31. W. Schramm, R.H. Smith, P.A. Craig, and D.A. Kidwell. Drugs of abuse in saliva: a review. J. Anal. Toxicol. 16: 1-9 (1992).
32. A.P. Jonsson. Mass spectrometry for protein and peptide characterisation, Cell. Mol. Life Sci. 58(7): 868-884 (2001).
33. L.F. Marvin, M.A. Roberts, and L.B. Fay. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in clinical chemistry. Clin. Chim. Acta 337(1-2): 11-21 (2003).
34. I. Ferrer, C.E. Heine, and E.M. Thurman. Combination of LC/TOFMS and LC/ion trap MS/MS for the identification of diphenhydramine in sediment samples. Anal. Chem. 76(5): 1437-1444. (2004).
35. M.W. Nielen, T.F. Bovee, M.C. van Engelen, P. Rutgers, A.R. Hamers, J.H. van Rhijn, and L.R. Hoogenboom. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification. Anal. Chem. 78(2): 424-431 (2006).
36. S. Marchese, A. Gentili, D. Perret, G.D. Ascenzo, and F. Pastori. Quadrupole time-of-flight versus triple-quadrupole mass spectrometry for the determination of non-steroidal antiinflammatory drugs in surface water by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 17(9): 879-886 (2003).
37. I. Ojanpera, A. Pelander, S. Laks, M. Gergov, E. Vuori, and M. Witt. Application of accurate mass measurement to urine drug screening. J. Anal. Toxicol. 29: 34-40 (2005).
38. J. Hughes, C. Borges, M. Slawson, J. Taccogno, D.J. Crouch, and B. Wuest. Detection and confirmation of anabolic steroids and metabolites in urine using routine accurate mass API-TOF LC/MS. Recent advances in doping analysis. Proceedings of the 23rd Cologne Workshop in Doping Analysis. Cologne, Germany, 2005.
39. E.R. Garrett and C.A. Hunt. Physiochemical properties, solubility, and protein binding of delta9-tetrahydrocannabinol. J. Pharm. Sci. 63(7): 1056-1064 (1974).
40. R.L. Foltz, K.M. McGinnis, and D.M. Chinn. Quantitative measurement of delta 9-tetrahydrocannabinol and two major metabolites in physiological specimens using capillary column gas chromatography negative ion chemical ionization mass spectrometry. Biomed. Mass Spectrom. 10(5): 316-323 (1983).
41. U.S. Department of Health and Human Services, Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, Beltsville, MD, 2001.
42. V.P. Shah, K.K. Midha, J.W. Findlay, H.M. Hill, J.D. Hulse, I.J. McGilveray, G. McKay, K.J. Miller, R.N. Patnaik, M.L. Powell, A. Tonelli, C.T. Viswanathan, and A. Yacobi. Bioanalytical method validation - a revisit with a decade of progress. Pharm. Res. 17: 1551-1557 (2000).
43. D. Dadgar, P.E. Burnett, M.G. Choc, K. Gallicano, and J.W. Hooper. Application issues in bioanalytical method validation, sample analysis and data reporting. J. Pharm. Biomed. Anal. 13(2): 89-99 (1995).
44. R. Bonfiglio, R.C. King, T.V. Olah, and K. Merkle. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compound. Rapid Commun. Mass Spectrom. 13: 1175-1185 (1999).
45. C.A. Hunt, R.T. Jones, R.I. Herning, and J. Bachman. Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in man. J. Pharmacokinet. Biopharm. 9(3): 245-260 (1981).
46. L.K. Thompson and E.J. Cone. Determination of delta 9- tetrahydrocannabinol in human blood and saliva by high-performance liquid chromatography with amperometric detection. J. Chromatogr. 421(1): 91-97 (1987).
47. O. Quintela, D.J. Crouch, and D.A. Andrenyak. Recovery of drugs of abuse from the Immunalysis Quantisal™ oral fluid collection device. J. Anal. Toxicol. 30: 614-616 (2006).
48. 9- tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays. J. Anal. Toxicol. 30: 413-418 (2006).